Dr. Liz Kwo has spearheaded transformative medicine as a serial physician entrepreneur. With extensive experience across multiple healthcare sectors, she propels companies to the forefront of digital innovation by leveraging groundbreaking technologies.
Dr. Kwo is the Chief Commercial Officer of Everly Health, a digital health company focused on modern diagnostics. Dr. Kwo authored “DIGITAL MD: Revolutionizing the Future of Care” and served as Deputy Chief Clinical Officer for Elevance (NYSE: ELV), a health insurance company dedicated to modernizing care for 43 million Americans, leveraging advanced data analytics in clinical management. Prior to this, Dr. Kwo was CEO and co-founder of InfiniteMD, a technology-enabled platform for international medical second opinions, which was acquired by Consumer Medical. She was also co-founder and President of New Pathway Education and Technology Group, which was acquired by EIC Education.
Dr. Kwo is on the board of Asensus Surgical (NYSE AMERICAN: ASXC), Walmart Mexico and Central America (BMV: WALMEX), BlueWind Medical, and ChroniSense Medical. She has been recognized by FierceHealthcare's 2020 Women of Influence Award, WomenTech Global 2021 AI Inclusion Award, and Healthcare Technology Report’s 2022 Top 25 Women Leaders in Biotechnology.
Dr. Kwo is board-certified in Preventive Care and Occupational Medicine and received a BA in Human Biology from Stanford University, an MD from Harvard Medical School, an MBA from Harvard Business School, and an MPH from Harvard T.H. Chan School of Public Health.